Ticker

1911 Gold Corp (TSX-V:AUMB, OTCQB:AUMBF, FRA:2KY) reported zero reportable environmental incidents and zero regulatory fines or penalties in 2025, according to its first sustainability report, covering its True North Gold Project in southeastern Manitoba.  The report covers the 2025 calendar year and highlights the company's commitment to transparency, safe and responsible operations, and engagement with Indigenous…

1911 Gold Corp (TSX-V:AUMB, OTCQB:AUMBF, FRA:2KY) reported new underground drilling results from its True North project, with CEO Shaun Heinrichs pointing to resource growth, an upcoming resource update and an accelerating drilling program as key developments for the company.  Heinrichs told Proactive that the latest program targeted an area accessible from Level 16 that was particularly relevant because it fell…

Rapport Therapeutics stock fell ~18% as investors digested updates on lead candidate RAP-219 and anticipated Phase 2 bipolar mania data. RAP-219 shows strong efficacy in focal onset seizures, with up to 90% median reduction in clinical seizures, supporting optimism for Phase 3 success. Analysts remain focused on the FOS opportunity, viewing the upcoming bipolar mania readout as potentially more instructive for…

A fat dividend yield can signal a screaming buy or a slow-motion disaster, and the difference hides in coverage math most investors never check.

A fat dividend yield can signal a stock worth buying or a company quietly falling apart, and telling the difference requires looking past the payout itself at the cash flow, debt load, and share price collapse hiding behind the number.